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CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung 
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Abstract
Inhalation of agricultural occupational dusts from swine confinement facilities can result in lung 
inflammation. The innate immune response to organic barn dusts results in production of a number 
of pro-inflammatory factors in the lungs of barn workers such as cytokines, chemokines, and an 
influx of neutrophils. Many of these inflammatory factors are influenced by the chemokine 
CXCL8/IL-8 (KC or MIP-2 in mice). Previously, we have demonstrated that an endotoxinin-
dependent component of swine barn dust extract (SBE) elevates lung chemokines in a protein 
kinase C (PKC)-dependent manner resulting in the significant formation of lung inflammatory cell 
infiltrates in a mouse model of SBE injury. In this study we test the ability of a CXCR1/CXCR2 
antagonist, CXCL8(3-74)K11R/G31P (G31P) to block many of the features of lung-inflammation 
in response to challenge with SBE in an established mouse exposure system. Injection of G31P 
concurrent with SBE nasal instillation over a course of 3 weeks significantly reduced neutrophil 
accumulation in the lungs of barn dust exposed animals compared to those given SBE alone. 
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There was a similar reduction in pro-inflammatory cytokines and chemokines IL-6, KC, and 
MIP-2 in SBE plus G31P-treated mice. In addition to excreted products, the receptors ICAM-1, 
CXCR1, and CXCR2, which all were elevated with SBE exposure, were also decreased with 
G31P treatment. SBE activation of PKCα and PKCε was reduced as well with G31P treatment. 
Thus, G31P was found to be highly effective at reducing several features of lung inflammation in 
mice exposed to barn dust extracts.
Introduction
Workers in animal confinement facilities are at a greater risk for contracting a variety of 
lung disorders such as chronic bronchitis, acute respiratory distress syndrome (ARDS), 
hypersensitivity pneumonitis, as well as developing asthma or COPD (Iversen et al. 2000, 
283–288; Radon et al. 2001, 405–410). Those even acutely exposed to these environments 
show clear signs of airway inflammation (Cormier et al. 1997, 1516–1522; Wang et al. 
1997, 381–387). Work by several groups has shown that organic dust inhalation from these 
facilities is associated with these symptoms (Cormier et al. 1997, 1516–1522; Dosman et al. 
2006, 761–766). The inflammation seen in response to these dusts is the result of innate 
immune responses to bacterial components from these facilities such as proteoglycans and 
endotoxin. In particular the toll-like receptors (TLRs) TLR2 and TLR4 are crucial to organic 
dust responses (Poole and Romberger 2012, 126–132). Signaling through these receptors 
results in the expression of an array of cytokines and chemokines, in particular the potent 
pro-inflammatory chemokine IL-8 (CXCL8).
PKCα and PKCε play a critical role in the inflammatory response to barn dust (Wyatt et al. 
2010, 706–715). Barn dust stimulates a sequential activation of PKC isoforms and cytokines 
in isolated airway epithelial cells. PKCα is activated within an hour and is required for 
TNFα and IL-6 production. TNFα precedes IL-6 production and subsequently activates 
PKCε, which is required for eventual IL-8 production several hours later. The effects of 
PKCs extend beyond just cytokines as cell surface adhesion markers responsible for 
neutrophil migration such as ICAM-1 are also up-regulated in response to PKCα activation 
(Mathisen et al. 2004, 1738–1744). Thus the activity of both protein kinases is critical to 
inflammation in response to barn dust.
The receptors for IL-8 in humans are the chemokine receptors CXCR1 and CXCR2. Both 
are high-affinity receptors for IL-8, but are capable of binding other chemokines (Ahuja, 
Lee, and Murphy 1996, 225–232; Fan et al. 2007, 11658–11666). In the mouse, IL-8 is 
functionally replaced by keratinocyte factor (KC) and MIP-2 (Lee et al. 1995, 2158–2164; 
Fan et al. 2007, 11658–11666) that bind these same CXCR1 and CXCR2 receptors (Fan et 
al. 2007, 11658–11666). A wide variety of cells are known to express either CXCR1 or 
CXCR2 and thus be signaled by these chemokines. Binding of IL-8 to CXCR1 or CXCR2 
can produce a host of chemotactic and antimicrobial responses resulting in increased 
neutrophil recruitment into the lung (Murphy 1997, 311–318; Tateda et al. 2001, 2017–
2024; Feniger-Barish et al. 1999, 996–1009). Therefore, successful blocking of CXCR1 and 
or CXCR2 is of great therapeutic interest for the control of inflammation. Indeed, there are 
currently CXCR2 agonists under development for diseases such as cystic fibrosis, 
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neutrophilic asthma and COPD that have been studied in human models of LPS (Leaker, 
Barnes, and O’Connor 2013, 137-9921-14-137) and ozone exposure (Lazaar et al. 2011, 
282–293; Holz et al. 2010, 564–570).
The IL-8 analog, G31P, has been shown to antagonize neutrophil migration and can bind 
CXCR1 and CXCR2 with a higher affinity than even IL-8 (Li, Zhang, and Gordon 2002, 
939–944). As IL-8 has a higher affinity for CXCR1 and CXCR2 than other ELR-CXC 
chemokines, it has been suggested that G31P may block most chemokine binding to these 
receptors (Li, Zhang, and Gordon 2002, 939–944). In a bovine system G31P has been shown 
to be effective at reducing cytokine production and neutrophil migration in response to LPS 
(Gordon et al. 2005, 1265–1272).
As exposure to organic dust results in significant IL-6 and KC production and neutrophilia 
in the lung (Poole et al. 2009, L1085–95), we hypothesized that G31P could effectively 
inhibit chemokine responses in a mouse model of organic swine barn dust extract (SBE) 
exposure. We also looked at commonly induced features of barn dust exposure such as 
activation of signaling molecules (PKCα and PKCε) and increased cell migration (lavage 
cell counts and ICAM-1 expression). We show here that G31P was useful in reducing 
neutrophilia in mice exposed to SBE. Lung responses also showed reductions in the 
cytokines, chemokines, and activation of PKC isoforms measured. Finally, the expression of 
ICAM-1, CXCR1, and CXCR2 appeared elevated by SBE exposure but were reduced in a 
number of cell types in the lungs of mice receiving G31P. Taken together we show G31P is 
a potent inhibitor of the innate immune response to barn dust.
Materials and Methods
Hog confinement dust extract preparation
Extracts were created as described previously (Mathisen et al. 2004, 1738–1744) from 
settled dust collected from hog confinement buildings. Briefly, SBE was made by mixing 10 
g of collected dust in 10 ml PBS (Dulbecco’s phosphate buffered saline, pH 7.4, Gibco, 
Frederick, MD) without calcium at room temperature for 1 hr. The mixture was then 
centrifuged 10 min, and supernatant saved and centrifuged a second time for 10 min before 
sterile filtering the supernatant. The barn dust used has been previously characterized (Poole 
et al. 2010, 684–700) as containing protein (1–2 mg/ml), endotoxin (22.5–48.75 EU/ml), 
and muramic acid (400 pmol/mg) in a 5% extract. A variety of bacterial sources 
(Clostridium ssp., Lactobacillus ssp., Ruminococcus ssp., and Eubacterium ssp.) contribute 
these toxins as recently characterized (Boissy et al. 2014, e95578).
Mouse exposure to SBE
All animal procedures were approved by the Institutional Animal Care and Use Committee 
of the University of Nebraska Medical Center. Female 6–8 weeks old C57BL/6 mice 
(Charles River, Wilmingtom, MA), were acclimated to facilities for one week after arrival. 
The animals were group-housed, and their diet consisted of commercial rodent chow and 
water ad libitum. Mice were weighed weekly and no significant changes in body weight 
were observed under any experimental condition (data not shown). Mice were assigned 
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randomly to each of the treatment groups: control, control + G31P administration, SBE 
instillation (12.5%), or SBE instillation + G31P. All mice (4 per group) were instilled 
nasally (Bailey et al. 2008, L1049–L1054) with 50 μl of treatment once every day for 5 days 
a week (Monday to Friday) for 3 weeks. Mice given G31P were injected peritoneally with 
250 μg/kg every 2 days. At end of study, mice were sacrificed by injection with sodium 
pentobarbital (100 μl, 75mg/ml). The experiment was conducted twice, one week apart, and 
data pooled.
Bronchiolar alveolar lavage (BALF) collection
Lungs were lavaged as described previously (Poole et al. 2009, L1085–95). Briefly, lungs 
were washed three times with 1 ml sterile saline each time. Lavage fluid was centrifuged 
1750g for 10 min and supernatant stored at −80°C prior to ELISA analysis. Cells were 
resuspended in 1 ml PBS, counted, and 1.5 × 103 cells were adhered to glass slides via 
cytospin onto glass slides. Cells were stained using a Diff-Quik kit (Siemens Healthcare 
Diagnostics, Newark, DE) and cover slips mounted. A differential count of at least 300 cells 
was made based on morphometric criteria and expressed as absolute cell numbers (mean +/− 
SEM).
Histology and immunohistochemical staining
After bronchoalveolar lavage, lungs were inflated with 10% buffered formalin and hung 
under 17 cm H2O pressure for 24 hr, after which they were placed in formalin for an 
additional 48 hr. Sections were cut at 5 mm thickness for staining. Sections were 
deparaffinized in Protocol Safeclear II (Fisher Scientific, Kalamazoo, MI) and rehydrated 
through an ethanol gradient (100%, 95%, 80%, 50%) and rinsed. One set of slides was 
stained with hematoxylin and eosin for histological examination while others were used for 
immunohistochemical examination.
For immunohistochemistry, antigen unmasking was accomplished by incubating slides in 
Diva Decloaker solution (Biocare Medical, Concord, CA) at 98°C for 20 min, followed by 
an additional 20 min where the solution was allowed to slowly cool to room temperature. 
After further rinsing in PBS, slides were blocked 30 min at room temperature in 5% skim 
milk in PBS. Antibodies to CXCR1 (Bioss, Woburn MA) or CXCR2 (Abcam, Cambridge 
MA) were subsequently added in 5% skim milk at 1:50 concentration and slides incubated 
overnight at 4° C. After washing the next day with PBST (PBS + 0.05% Tween-20 pH 7.4), 
slides were incubated with biotinylated rabbit anti-goat antibody (goat anti-rabbit-HRP, 
Jackson Immunoresearch, West Grove, PA) at 1:50 concentration overnight at 4° C. Slides 
were washed in PBS then developed with ImmPACT DAB kit (Vector, Burlingame, CA) for 
3 min and counterstained with Harris-modified hematoxylin (Fisher Scientific, FairLawn, 
NJ) before being dehydrated through an ethanol gradient and fixed with Safeclear II. 
Samples were mounted using Cytoseal XYL (Thermo Scientific, Kalamazoo MI). For 
CD54/ICAM-1, staining was completed as mentioned previously (Poole et al. 2009, L1085–
95). Briefly, blocking was done overnight at 4° C, with primary antibody added at 1:75 (rat 
anti-mouse ICAM-1; Rockland Immunochemicals, Gilbertsville, PA) and incubated for 1 hr 
at room temperature, and secondary (rat anti-CD54, 1:300; Biolegend, San Diego, CA) for 2 
hr.
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Lung trachea was taken from mice after lavage was completed. These trachea were flash 
frozen in cell lysis buffer as described (Wyatt et al. 2000, 91–97). Bronchial epithelial cells 
were sonicated and centrifuged 10000 × g for 30 min at 4° C and supernatant and pellet 
separated and resuspended in cell lysis buffer with 0.01% Triton X-100. Assay for isoforms 
α and ε of PKC in each fraction were carried out as previously described (Wyatt et al. 2007, 
L1163–L1170) and read by scintillation counter.
Cytokine and chemokine quantitation
Cytokine and chemokine quantitation of BALF fluid was done by enzyme linked 
immunoabsorbant assay kits to IL-6, KC, and MIP-2 (R&D Systems, Minneapolis, MN), 
according to manufacturer’s instructions.
Statistical analysis
All data was analyzed using GraphPad Prism (GraphPad Software, San Diego, CA). Graph 
bars represent the mean +/− SE of three replicate experiments performed in triplicate (n=3). 




Cells in BALF were counted and identified to determine migration of both number and type 
of cells into the alveoli. SBE significantly increased the overall number of cells in BALF 
(Fig. 1A). However, pre-treatment of SBE-treated animals with G31P significantly 
(p<0.001) reduced the number of these cells, though the number of cells was still higher than 
non-SBE treated control groups. When the type of cells present was determined (Fig. 1B), 
control and G31P-only treated animals had BALF cellular populations that were almost 
entirely macrophages. With SBE treatment, this population however became dominated by 
neutrophils, accounting for a large proportion of the overall increase in BALF total cell 
numbers. Pre-treatment of SBE-treated animals with G31P significantly (p<0.001) reduced 
the percentage of neutrophils within the BALF cell population compared to SBE-only 
treated mice. G31P pretreatment did not completely abrogate the number of neutrophils 
present compared to control groups.
Cytokine and chemokine expression to SBE is decreased with G31P
Because G31P significantly reduced the numbers of neutrophils in the BALF in response to 
SBE, we determined whether G31P caused changes in SBE-stimulated chemotactic 
cytokines. Control and Control + G31P treated animals produced little to near undetectable 
amounts of either KC or MIP-2 (Fig. 2A and 2B) in their BALF, whereas treatment with 
SBE caused a significant increase in both. SBE-instilled mice treated with G31P showed a 
significant (p<0.001) drop in the expression of each chemokine, though not a total 
elimination of either. Another indicator of inflammation, IL-6 (Fig. 2C), followed the same 
pattern (p<0.01) of expression as KC and MIP-2.
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G31P blocks stimulation of PKCα and PKCε activity in lung tissue
Airway epithelial cells harvested from tracheal tissue of mice and precisioncut lung slices 
were tested for catalytic PKC activity. Past work has shown that PKC activation is also a 
feature of SBE exposure (Wyatt et al. 2007, L1163–L1170; Romberger et al. 2002, 289–
296). Mice exposed to SBE showed clearly significant (p<0.01) PKCα and PKCε activation 
(Fig. 3A and 3B respectively) in both tracheal epithelial cells and precision-cut lung slices 
(Fig. 3C and 3D respectively). In contrast those exposed to SBE that were given G31P 
showed minimal activity of either kinase.
Histological Examination
Examination of lung sections that were stained with hematoxylin and eosin revealed no 
apparent increases in lung infiltration in the control (Fig 4A) or control + G31P (Fig. 4B) 
treated animals. Animals that were given SBE however showed clear indications of 
increased cellularity in the alveoli as well as formation of foci of peribronchial mononuclear 
cells (Fig 4C, arrow), typical of such dust instillations into these animals. SBE + G31P 
treated animals showed some increase in cellular infiltration over controls similar to the SBE 
treated mice, but few if any mononuclear foci were apparent (Fig. 4D). This demonstrates 
that G31P was effective at blocking formation of these dust-induced mononuclear cell 
aggregates.
Expression of CD54/ICAM-1 is reduced by G31P
Work by others has shown that ICAM-1 is increased in the bronchial epithelium after 
exposure to barn dust (Mathisen et al. 2004, 1738–1744), and as an important neutrophil 
chemotactic factor may play a role in neutrophil migration (Reviewed in Springer 1994, 
301–314). Staining of the bronchial epithelium of mouse lungs using an ICAM-1 specific 
antibody clearly showed an increase in the expression of ICAM-1 in the bronchial 
epithelium of SBE treated mice (Fig. 5B) compared to saline treated animals (Fig. 5A). The 
administration of G31P did not induce ICAM-1 (Fig. 5C), but in SBE-treated animals (Fig 
5D) it was able to inhibit the increased ICAM-expression, eliminating most if not all 
ICAM-1 staining of the bronchial epithelium.
Expression of CXCR1 and CXCR2 is reduced by G31P
As no previous work exists on the effect of G31P on its receptors CXCR1 and CXCR2, we 
examined their expression in our model. Expression of both CXCR1 and CXCR2 was 
readily apparent in the lung (Fig 6). Control saline-treated animals showed strong expression 
of both receptors on macrophages within the alveolar space (Fig. 6A, 6B). There was also 
staining within the alveolar walls, though this was not present through all cells. There was 
however clear staining of the bronchial epithelium. Administration of G31P (Fig. 6C, 6D) 
eliminated staining of both receptors in the alveolar walls and the bronchial epithelium, 
however alveolar macrophages still stained clearly for both receptors.
With SBE treated animals (Fig. 6C), there was a general increase of both receptors through 
all locations described above, with the exception of weaker (but still apparent) staining of 
the bronchial epithelium for CXCR2. SBE-treated animals given G31P (Fig. 6D) showed 
decreases in staining of both these receptors, particularly in the alveolar walls and the 
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bronchial epithelium, the latter of which showed only very faint staining for either receptor. 
As with the control + G31P animals, expression was still strong in cells within the alveolar 
space, however, we noted that unlike the SBE group not all of the cells in these alveolar 
spaces were stained.
Discussion
Lung inflammation and innate immune responses in the lung are a critical part of the 
immune system. These rapid and often vigorous responses are vital to the rapid containment 
and elimination of potential pathogens we are exposed to on a daily basis. Excessive 
inflammation in the lung however can rapidly lead to pathology and a loss of gas exchange 
function. Organic barn dusts represent an environmental exposure where such inflammatory 
responses may often be mal-adaptive. Immune responses to these dusts can be rapid 
(Gamage et al. 2007, 18; Dosman et al. 2004, 698–702) or prolonged and chronic 
(Senthilselvan et al. 1997, 1733–1741; Kirychuk et al. 2003, 375–380). Much of these 
responses appears directed to proteoglycans and lipopolysaccharides present in these dusts, 
signaling through toll-like receptors such as TLR2 and TLR4 (Reviewed in Poole and 
Romberger 2012, 126–132). In this case, no live organisms need be present to induce these 
vigorous innate responses.
A feature that has been shown to be critical in limiting lung inflammation is inhibiting the 
migration of neutrophils into the lung (Grommes and Soehnlein 2011, 293–307). As such, 
we examined the BALF of mice to determine if G31P had any effect on neutrophil migration 
in response to SBE. Total cell number in the BALF of SBE exposed animals was 
significantly elevated compared to control animals as others have shown (Poole et al. 2009, 
L1085–95), with the predominance of cells shifting from macrophages to neutrophils, 
indicating a large influx of these cells into the lungs, and presumably a more neutrophil-
driven response. Treatment with G31P prevented much of this cellular influx into the lung. 
While some of this influx may still be neutrophils, the predominant lavage cell by numbers 
is again the alveolar macrophage. This lowering of neutrophil migration, and presumed 
activation in the lung will also contribute to limiting lung inflammation and damage.
Cytokine and chemokine expression, particularly IL-8 and IL-6 are good indicators of lung 
inflammation. Increased production of IL-6 and KC are common with SBE exposure (Poole 
et al. 2009, L1085–95; Bailey et al. 2008, L1049–L1054; Wyatt et al. 2007, L1163–
L1170)and important in inducing cell migration and activation (Tsai et al. 1998, 2435–2440; 
Biffl et al. 1996, 575–8; discussion 578–9). In the mouse, the structurally similar KC, and 
the closely related chemokine MIP-2 cover the same functions as IL-8 in humans. KC is 
shown to bind CXCR1 while MIP-2 binds to CXCR2 (Ahuja, Lee, and Murphy 1996, 225–
232; Fan et al. 2007, 11658–11666), though other chemokines may bind each receptor. Both 
chemokines may act in an autocrine fashion (Vanderbilt et al. 2003, 661–668)so blocking 
cytokine/chemokine receptor binding may also reduce native chemokine production. 
Therefore, we wished to see if the G31P inhibitor could block the expression of new KC and 
MIP-2 expression, as both are strongly induced with SBE exposure. We showed that indeed 
G31P is effective at reducing the expression of both chemokines induced to SBE exposure 
as well as IL-6, the last of which is capable of activating a number of neutrophil 
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antimicrobial functions (Biffl et al. 1996, 575–8; discussion 578–9). Therefore, in 
considering G31P effectiveness we must also consider reduced KC, MIP-2, and IL-6 
expression due to reduced intracellular activation in the lungs as another possible reason for 
the reduced inflammation observed.
Previous work from our lab has established that exposure to SBE can induce the activation 
of PKC in cells, in particular PKCα and PKCε (Romberger et al. 2002, 289–296; Poole et al. 
2009, L1085–95; Poole et al. 2007, 366–373; Wyatt et al. 2007, L1163–L1170). As others 
have shown, PKCα may interact with TLR receptor via adaptor protein MyD88, and is 
critical in their signaling to increase downstream migration of transcription factors MAPK, 
NF-κB, and AP-1 to the nucleus (Langlet et al. 2010, 505–515). Similarly, PKCε is 
phosphorylated by all MyD88-associated TLRs and failure to do so results in a lack of NF-
κB induction (Faisal et al. 2008, 18591–18600). Therefore, both PKCs are good indicators 
of TLR activation and signaling and potentially have critical effects on TLR-induced 
immune responses. Our results show that G31P can significantly reduce activation of both 
PKCs in response to SBE. As a role has been established for MyD88 in the induction of both 
KC and MIP-2 (Langlet et al. 2010, 505–515; De Filippo et al. 2008, 4308–4315; 
Orlichenko et al. 2010, G867-G876) this may also explain the similarly reduced expression 
of both chemokines.
Expression of the receptor CXCR2 can be found in airway epithelium (Schulz et al. 2012, 
108–116; Farkas et al. 2005, 3724–3734), vascular endothelium (Schraufstatter, Chung, and 
Burger 2001, L1094–L1103), type-II cells (Vanderbilt et al. 2003, 661–668), and fibroblasts 
(Dunlevy and Couchman 1995, 311–321), many of which may be vital to neutrophil 
migration such as in the endothelium (Reutershan et al. 2006, 695–702). The research on 
CXCR1 in mice is more limited than in humans, due in part to a much later discovery of 
analogous function (Fan et al. 2007, 11658–11666). Binding CXCR1 or CXCR2 can induce 
internalization of these receptors that requires replacement of said receptors by protein 
synthesis (Cummings et al. 1999, 2341–2346). CXCR1 and CXCR2 mRNA expression was 
found to be induced by inflammatory stimuli coincident with increase of KC, GCP-2, and 
MIP-2 (Fan et al. 2007, 11658–11666). Because we showed that G31P can reduce 
expression of two of these chemokines, we postulated G31P could have an impact on 
expression of CXCR1 and CXCR2 proteins. We show that both receptors were expressed on 
the bronchial epithelium, some cells within the alveolar walls/septa, and cells within the 
alveolar space. Given our BALF results, these cells of the alveolar space should be 
macrophage as these are all we find in untreated animals. The positive cells within the 
alveoli septa are harder to clearly determine. The most likely candidates are type-II alveolar 
cells and/or fibroblasts (Vanderbilt et al. 2003, 661–668; Dunlevy and Couchman 1995, 
311–321). With G31P treatment, CXCR1 and CXCR2 expression appears to be eliminated 
or greatly reduced in all cells except the alveolar macrophages. These patterns of expression 
appeared to be similar but with much higher overall expression of CXCR1 and CXCR2 in 
SBE exposed animals. To rule out the possibility of G31P interfering with antibody binding 
to target proteins we tested antibody binding to purified CXCR1 and CXCR2 proteins via 
dot blot with and without G31P, noting no change in staining efficiency (data not shown). In 
SBE-treated animals, additional cells in the alveolar spaces were present and also stained 
positively for CXCR1 and CXCR2. Because our lavage data does not support an increase in 
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macrophages, these additional cells are likely neutrophils. As with the control animals, 
G31P treatment eliminated much of the staining for either receptor in the alveolar septa of 
SBE-treated animals, however this was not complete and some staining was still present. 
Bronchial epithelial cells, while clearly showing reduced CXCR1 and CXCR2 expression 
with G31P treatment also showed what appears to be a slight reduction in CXCR2 in SBE-
treated animals. While we know of no mention of this in the literature, CXCR2 reduction in 
sepsis as a result of slow receptor turnover has been demonstrated in neutrophils (Cummings 
et al. 1999, 2341–2346). While we did not see an apparent reduction of CXCR2 staining in 
the alveolar macrophages with G31P treatment, staining was so intense in these cells with all 
treatments that a more sensitive method may need to be employed to determine if such 
changes do take place.
Taken together we propose that the ability of G31P to inhibit inflammation and neutrophil 
migration into the lung may be mediated at several levels. Treatment prevents or greatly 
inhibits chemokine signaling to a number of cell types such as epithelial and type-II cells 
(Zhao et al. 2009, 3213–3222). This could then result in reduction in PKCα and PKCε 
activation and production of cytokines, chemokines, or receptor expression, such as 
ICAM-1, and CXCR1 and CXCR2. Reduced CXCR1 and CXCR2 expression would further 
limit potential stimulatory signaling. Reductions of both chemokines and ICAM-1, the latter 
of which is vital to neutrophil migration (Tosi et al. 1992, 214–221)and upregulated in 
response to organic dusts (Mathisen et al. 2004, 1738–1744)will reduce neutrophil 
migration. Finally, neutrophils reaching the lung will be deprived of important signals for 
cytokine production, degranulation, formation of reactive oxygen species, or survival 
through reduced chemokine signaling (Biffl et al. 1996, 575–8; discussion 578–9).
Whatever the precise mechanism, we show that the IL-8 analog G31P is effective at 
blocking several key indicators of lung inflammation in response to organic dusts, and may 
be a viable therapy to consider for chronic organic dust exposure-induced lung injury.
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Mean total of lung lavage fluid cells (A) and percent composition of macrophage (mac) and 
neutrophils (PMN) in lavage cells (B) after repeated nasal instillation with saline, SBE, 
G31P, or SBE+G31P. Error bars are SE (n=8 mice/group). ***P < 0.001, ****P < 0.0001
Schneberger et al. Page 13














Mean lung lavage fluid cytokine expression of KC (A), MIP-2 (B), and IL-6 (C). Error bars 
are SE (n=8 mice/group). **P < 0.01, ***P < 0.001
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PKC activity. Lung trachea (A and B) and lung slices (C and D) were measured for PKCa 
and PKCε activity from saline, SBE, G31P and SBE+G31P treated mice. **P < 0.01
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Hematoxylin and eosin staining of mouse lung from mice treated with saline (A), G31P (B), 
SBE (C), and SBE+G31P (D). No change was apparent in G31P treatment compared to 
Saline. SDE induced. SBE induced increased cellularity and peribronchial foci of 
mononuclear cells (arrow), both of which were reduced with G31P co-administration.
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ICAM-1 staining of mouse lung from mice treated with saline (A), G31P (B), SBE (C), and 
SBE+G31P (D). ICAM-1 (brown stain) was expressed on bronchial epithelium of SDE 
treated mouse lung, but eliminated with co-administration of G31P.
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Mouse lung staining for CXCR1 (A,C,E,G) and CXCR2 (B,D,F,H). Both receptors were 
clearly expressed in alveolar epithelium, bronchial epithelium, and alveolar macrophages. 
Levels of both receptors in Saline (A,B) appeared reduced in G31P treated animals (C,D), 
particularly in the bronchial epithelium (inset images). SDE treated animals (E,F) showed 
increased expression of both receptors, and G31P treatment (G,H) was able to reduce this, 
particularly in bronchial epithelium (inset images).
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